Search research articles
Contact Us
Filters
Showing results (841-850 of 920) with videos related to
Page
of 92
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone
Fei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Cancer Immunology, Immunotherapy : CII
|
October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
Jin-Ji Yang, Cheng Huang, Yun Fan, et al.
The Lancet. Respiratory Medicine
|
June 24, 2021
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
Shun Lu, Jian Fang, Xingya Li, et al.
JTO Clinical and Research Reports
|
June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLC
Alexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Gastroenterology
|
November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B
Yun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Chemistry & Biodiversity
|
December 19, 2025
Anticancer, Anti-Inflammatory, and Acute Toxicological Evaluation of the Novel Berberine Derivative BN-7
Ren-Tao Zhang, Qi-Qi Xie, Xiao-Long Sun, et al.
JAMA Oncology
|
September 2, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Leora Horn, Ziping Wang, Gang Wu, et al.
Signal Transduction and Targeted Therapy
|
October 15, 2021
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
Tao Jiang, Pingyang Wang, Jie Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 15, 2024
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
Ying Cheng, Lin Wu, Dingzhi Huang, et al.
Cell Research
|
June 23, 2010
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism
Wei Zhao, Yi Zhong, Hua Yuan, et al.
Page
of 92
Search research articles
Search
Showing results (841-850 of 920) with videos related to
Sort By:
Page
of 92
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone
Fei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Cancer Immunology, Immunotherapy : CII
|
October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
Jin-Ji Yang, Cheng Huang, Yun Fan, et al.
The Lancet. Respiratory Medicine
|
June 24, 2021
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
Shun Lu, Jian Fang, Xingya Li, et al.
JTO Clinical and Research Reports
|
June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLC
Alexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Gastroenterology
|
November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B
Yun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Chemistry & Biodiversity
|
December 19, 2025
Anticancer, Anti-Inflammatory, and Acute Toxicological Evaluation of the Novel Berberine Derivative BN-7
Ren-Tao Zhang, Qi-Qi Xie, Xiao-Long Sun, et al.
JAMA Oncology
|
September 2, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Leora Horn, Ziping Wang, Gang Wu, et al.
Signal Transduction and Targeted Therapy
|
October 15, 2021
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
Tao Jiang, Pingyang Wang, Jie Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 15, 2024
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
Ying Cheng, Lin Wu, Dingzhi Huang, et al.
Cell Research
|
June 23, 2010
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism
Wei Zhao, Yi Zhong, Hua Yuan, et al.
Page
of 92